SCHEMBL6947649

SCHEMBL6947649

CCNc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.41
KDM4E B2RXH2 10/20 0.41
MAPT P10636 7/20 0.41
NPSR1 Q6W5P4 4/20 0.41
PDE7A Q13946 2/20 0.40
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
HTT P42858 4/20 0.40
GAA P10253 2/20 0.40
POLB P06746 2/20 0.40
HIF1A Q16665 2/20 0.40
GRM2 Q14416 1/20 0.39
HSD17B10 Q99714 4/20 0.38
HPGD P15428 4/20 0.38
TP53 P04637 2/20 0.38
MAPK1 P28482 2/20 0.38
PKM P14618 1/20 0.38
GLA P06280 1/20 0.37
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950993 0.89 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6952171 0.88 GRM2 (0.39) ALDH1A1KDM4EMAPTNPSR1PDE7A
SCHEMBL6952709 0.84 GRM2 (0.42) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6949441 0.83 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6950036 0.80 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6945569 0.80 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6955474 0.79 GRM2 (0.39) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6950841 0.79 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6955743 0.78 GRM2 (0.39) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL6953105 0.78 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed